Evercore ISI近日开始覆盖Inspire Medical Systems,并给予该股"跑赢大盘"评级,同时设定目标价为150美元。
这一评级表明,Evercore ISI分析师对Inspire Medical Systems的未来表现持乐观态度,认为该股有望超越市场整体表现。150美元的目标价显示了分析师对公司前景的积极预期。
Evercore ISI近日开始覆盖Inspire Medical Systems,并给予该股"跑赢大盘"评级,同时设定目标价为150美元。
这一评级表明,Evercore ISI分析师对Inspire Medical Systems的未来表现持乐观态度,认为该股有望超越市场整体表现。150美元的目标价显示了分析师对公司前景的积极预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.